Status:
RECRUITING
Medipixel XA-Assisted PCI in Coronary Artery Disease
Lead Sponsor:
CHA University
Conditions:
Percutaneous Coronary Intervention (PCI)
Coronary Arterial Disease (CAD)
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
This prospective, multicenter, single-arm, interventional study evaluates the effectiveness and safety of Medipixel XA-Assisted Percutaneous Coronary Intervention (MPXA-PCI) in patients with coronary ...
Eligibility Criteria
Inclusion
- Silent ischemia, stable or unstable angina, or myocardial infarction
- De novo coronary lesion eligible for DES implantation
- Lesions analyzable by MPXA
Exclusion
- Comorbidity with a life expectancy \<12 months
- Intolerant of antithrombotic therapy
- Significant anemia, thrombocytopenia, or leucopenia
- History of major hemorrhage (intracranial, gastrointestinal, and so on)
- Chronic total occlusion lesion
- Left main lesion
- Severe calcification needing rotational atherectomy
- Lesions not analyzable by MPXA
Key Trial Info
Start Date :
May 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2028
Estimated Enrollment :
830 Patients enrolled
Trial Details
Trial ID
NCT06985693
Start Date
May 15 2025
End Date
May 1 2028
Last Update
May 22 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Chung-Ang University Gwangmyeong Hospital
Gwangmyeong, Gyeonggi-do, South Korea, 14351
2
CHA Bundang Medical Center
Seongnam-si, Gyeonggi-do, South Korea, 13496
3
Keimyung University Dongsan Medical Center
Daegu, South Korea, 42601
4
Chonnam National University Hospital
Gwangju, South Korea, 61469